These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 33752701)

  • 1. Plaque associated microglia hyper-secrete extracellular vesicles and accelerate tau propagation in a humanized APP mouse model.
    Clayton K; Delpech JC; Herron S; Iwahara N; Ericsson M; Saito T; Saido TC; Ikezu S; Ikezu T
    Mol Neurodegener; 2021 Mar; 16(1):18. PubMed ID: 33752701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer's disease patients and App
    Nuñez-Diaz C; Andersson E; Schultz N; Pocevičiūtė D; Hansson O; ; Nilsson KPR; Wennström M
    Alzheimers Res Ther; 2024 Jan; 16(1):4. PubMed ID: 38167557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knock-in models related to Alzheimer's disease: synaptic transmission, plaques and the role of microglia.
    Benitez DP; Jiang S; Wood J; Wang R; Hall CM; Peerboom C; Wong N; Stringer KM; Vitanova KS; Smith VC; Joshi D; Saito T; Saido TC; Hardy J; Hanrieder J; De Strooper B; Salih DA; Tripathi T; Edwards FA; Cummings DM
    Mol Neurodegener; 2021 Jul; 16(1):47. PubMed ID: 34266459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in Tau Pathology in P290S
    Huang M; Macdonald J; Lavenir I; Chen R; Craxton M; Slavik-Smith E; Davies SW; Goedert M
    eNeuro; 2022; 9(6):. PubMed ID: 36635241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology.
    Laversenne V; Nazeeruddin S; Källstig EC; Colin P; Voize C; Schneider BL
    Acta Neuropathol Commun; 2020 Nov; 8(1):198. PubMed ID: 33225991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice.
    Chen Y; Zhao S; Fan Z; Li Z; Zhu Y; Shen T; Li K; Yan Y; Tian J; Liu Z; Zhang B
    Alzheimers Res Ther; 2021 Feb; 13(1):40. PubMed ID: 33563332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enrichment of Neurodegenerative Microglia Signature in Brain-Derived Extracellular Vesicles Isolated from Alzheimer's Disease Mouse Models.
    Muraoka S; Jedrychowski MP; Iwahara N; Abdullah M; Onos KD; Keezer KJ; Hu J; Ikezu S; Howell GR; Gygi SP; Ikezu T
    J Proteome Res; 2021 Mar; 20(3):1733-1743. PubMed ID: 33534581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies.
    Casali BT; MacPherson KP; Reed-Geaghan EG; Landreth GE
    Neurobiol Dis; 2020 Aug; 142():104956. PubMed ID: 32479996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglial activation in the right amygdala-entorhinal-hippocampal complex is associated with preserved spatial learning in App
    Biechele G; Wind K; Blume T; Sacher C; Beyer L; Eckenweber F; Franzmeier N; Ewers M; Zott B; Lindner S; Gildehaus FJ; von Ungern-Sternberg B; Tahirovic S; Willem M; Bartenstein P; Cumming P; Rominger A; Herms J; Brendel M
    Neuroimage; 2021 Apr; 230():117707. PubMed ID: 33385560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of microglial depletion and TREM2 deficiency on Aβ plaque burden and neuritic plaque tau pathology in 5XFAD mice.
    Delizannis AT; Nonneman A; Tsering W; De Bondt A; Van den Wyngaert I; Zhang B; Meymand E; Olufemi MF; Koivula P; Maimaiti S; Trojanowski JQ; Lee VM; Brunden KR
    Acta Neuropathol Commun; 2021 Sep; 9(1):150. PubMed ID: 34503586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSK3β is involved in promoting Alzheimer's disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor protein
    Jiang M; Zhang X; Yan X; Mizutani S; Kashiwazaki H; Ni J; Wu Z
    Brain Behav Immun; 2021 Nov; 98():1-12. PubMed ID: 34391814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice.
    Kocherhans S; Madhusudan A; Doehner J; Breu KS; Nitsch RM; Fritschy JM; Knuesel I
    J Neurosci; 2010 Jul; 30(27):9228-40. PubMed ID: 20610758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-amyloid accumulation enhances microtubule associated protein tau pathology in an APP
    Jiang L; Roberts R; Wong M; Zhang L; Webber CJ; Libera J; Wang Z; Kilci A; Jenkins M; Ortiz AR; Dorrian L; Sun J; Sun G; Rashad S; Kornbrek C; Daley SA; Dedon PC; Nguyen B; Xia W; Saito T; Saido TC; Wolozin B
    Front Neurosci; 2024; 18():1372297. PubMed ID: 38572146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TDP-43 expression influences amyloidβ plaque deposition and tau aggregation.
    Davis SA; Gan KA; Dowell JA; Cairns NJ; Gitcho MA
    Neurobiol Dis; 2017 Jul; 103():154-162. PubMed ID: 28416393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice.
    Sanchez-Ramos J; Song S; Sava V; Catlow B; Lin X; Mori T; Cao C; Arendash GW
    Neuroscience; 2009 Sep; 163(1):55-72. PubMed ID: 19500657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia.
    Lodder C; Scheyltjens I; Stancu IC; Botella Lucena P; Gutiérrez de Ravé M; Vanherle S; Vanmierlo T; Cremers N; Vanrusselt H; Brône B; Hanseeuw B; Octave JN; Bottelbergs A; Movahedi K; Dewachter I
    Acta Neuropathol Commun; 2021 Jun; 9(1):108. PubMed ID: 34103079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of corticocortical connections ameliorates amyloid burden in terminal fields in a transgenic model of Abeta amyloidosis.
    Sheng JG; Price DL; Koliatsos VE
    J Neurosci; 2002 Nov; 22(22):9794-9. PubMed ID: 12427835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humanization of the entire murine
    Saito T; Mihira N; Matsuba Y; Sasaguri H; Hashimoto S; Narasimhan S; Zhang B; Murayama S; Higuchi M; Lee VMY; Trojanowski JQ; Saido TC
    J Biol Chem; 2019 Aug; 294(34):12754-12765. PubMed ID: 31273083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.